These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

458 related items for PubMed ID: 20035250

  • 21. The impact of donor spontaneous intracranial haemorrhage vs. other donors on long-term renal graft and patient survival.
    Johnston O, O'Kelly P, Spencer S, Cunningham P, Dorman A, Donohoe J, Walshe JJ, Hickey D, Little DM, Conlon PJ.
    Clin Transplant; 2006; 20(1):91-5. PubMed ID: 16556161
    [Abstract] [Full Text] [Related]

  • 22. A multi-factor analysis of kidney regraft outcomes.
    Gjertson DW.
    Clin Transpl; 2002; ():335-49. PubMed ID: 12971460
    [Abstract] [Full Text] [Related]

  • 23. Patient and graft outcomes from deceased kidney donors age 70 years and older: an analysis of the Organ Procurement Transplant Network/United Network of Organ Sharing database.
    Chavalitdhamrong D, Gill J, Takemoto S, Madhira BR, Cho YW, Shah T, Bunnapradist S.
    Transplantation; 2008 Jun 15; 85(11):1573-9. PubMed ID: 18551062
    [Abstract] [Full Text] [Related]

  • 24. Risk factors and outcomes analyses at 36 months of a prospective, randomized, multicenter, trial of daclizumab induction in simultaneous kidney-pancreas transplant recipients.
    Stratta RJ, Alloway RR, Lo A, Hodge EE.
    Transplant Proc; 2005 Oct 15; 37(8):3527-30. PubMed ID: 16298650
    [Abstract] [Full Text] [Related]

  • 25. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
    Meng HL, Jin XB, Li XT, Wang HW, Lü JJ.
    Chin Med J (Engl); 2009 Feb 20; 122(4):420-6. PubMed ID: 19302748
    [Abstract] [Full Text] [Related]

  • 26. Frequency and severity of acute rejection in live- versus cadaveric-donor renal transplants.
    Campbell SB, Hothersall E, Preston J, Brown AM, Hawley CM, Wall D, Griffin AD, Isbel NM, Nicol DL, Johnson DW.
    Transplantation; 2003 Nov 27; 76(10):1452-7. PubMed ID: 14657685
    [Abstract] [Full Text] [Related]

  • 27. Long-term outcomes of kidney transplantation in recipients 60 years of age and older at the University of Florida.
    Foley DP, Patton PR, Meier-Kriesche HU, Li Q, Shenkman B, Fujita S, Reed A, Hemming AW, Kim RD, Howard RJ.
    Clin Transpl; 2005 Nov 27; ():101-9. PubMed ID: 17424728
    [Abstract] [Full Text] [Related]

  • 28. [Acute rejection in cadaveric renal transplantation under cyclosporine based therapy. Analysis of the risk factors and its influence on chronic dysfunction].
    Mota A.
    Acta Med Port; 2004 Nov 27; 17(1):8-14. PubMed ID: 15636737
    [Abstract] [Full Text] [Related]

  • 29. Excellent renal allograft survival in donor-specific antibody positive transplant patients-role of intravenous immunoglobulin and rabbit antithymocyte globulin.
    Mai ML, Ahsan N, Wadei HM, Genco PV, Geiger XJ, Willingham DL, Taner CB, Hewitt WR, Grewal HP, Nguyen JH, Hughes CB, Gonwa TA.
    Transplantation; 2009 Jan 27; 87(2):227-32. PubMed ID: 19155977
    [Abstract] [Full Text] [Related]

  • 30. The UNOS Scientific Renal Transplant Registry.
    Cecka JM.
    Clin Transpl; 1999 Jan 27; ():1-21. PubMed ID: 11038622
    [Abstract] [Full Text] [Related]

  • 31. Advantages of kidney transplant precocity in graft long-term survival.
    Malho A, Malheiro J, Fonseca I, Martins LS, Pedroso S, Almeida M, Dias L, Castro Henriques A, Cabrita A.
    Transplant Proc; 2012 Oct 27; 44(8):2344-7. PubMed ID: 23026589
    [Abstract] [Full Text] [Related]

  • 32. What has changed in more than 40 years of activity and 3000 kidney transplants at Policlinico University Hospital, Milan.
    Berardinelli L, Raiteri M, Beretta C, Pasciucco A, Giussani A, Carini M, Marenghi C, Rossetti A, Piccolo G.
    Clin Transpl; 2011 Oct 27; ():99-110. PubMed ID: 22755406
    [Abstract] [Full Text] [Related]

  • 33. Transplanting kidneys from CMV-seropositive donors to CMV-seronegative recipients is not associated with poorer renal allograft function or survival.
    McLaughlin K, Sandhu S, Wu C, Muirhead N, Hollomby D, Jevnikar A.
    Nephrol Dial Transplant; 2005 Jan 27; 20(1):176-80. PubMed ID: 15572381
    [Abstract] [Full Text] [Related]

  • 34. Daclizumab is associated with decreased rejection and improved patient survival in renal transplant recipients.
    Morris JA, Hanson JE, Steffen BJ, Chu AH, Chi-Burris KS, Gotz VP, Gordon RD.
    Clin Transplant; 2005 Jun 27; 19(3):340-5. PubMed ID: 15877795
    [Abstract] [Full Text] [Related]

  • 35. Cold ischemia is a major determinant of acute rejection and renal graft survival in the modern era of immunosuppression.
    Mikhalski D, Wissing KM, Ghisdal L, Broeders N, Touly M, Hoang AD, Loi P, Mboti F, Donckier V, Vereerstraeten P, Abramowicz D.
    Transplantation; 2008 Apr 15; 85(7 Suppl):S3-9. PubMed ID: 18401260
    [Abstract] [Full Text] [Related]

  • 36. Interleukin-2 receptor antibody reduces rejection rates and graft loss in live-donor kidney transplant recipients.
    Lim WH, Chang SH, Chadban SJ, Campbell SB, Dent H, Russ GR, McDonald SP.
    Transplantation; 2009 Nov 27; 88(10):1208-13. PubMed ID: 19935375
    [Abstract] [Full Text] [Related]

  • 37. First year renal function as a predictor of kidney allograft outcome.
    Resende L, Guerra J, Santana A, Mil-Homens C, Abreu F, da Costa AG.
    Transplant Proc; 2009 Apr 27; 41(3):846-8. PubMed ID: 19376368
    [Abstract] [Full Text] [Related]

  • 38. Deceased-donor kidney transplantation: improvement in long-term survival.
    Serur D, Saal S, Wang J, Sullivan J, Bologa R, Hartono C, Dadhania D, Lee J, Gerber LM, Goldstein M, Kapur S, Stubenbord W, Belenkaya R, Marin M, Seshan S, Ni Q, Levine D, Parker T, Stenzel K, Smith B, Riggio R, Cheigh J.
    Nephrol Dial Transplant; 2011 Jan 27; 26(1):317-24. PubMed ID: 20656753
    [Abstract] [Full Text] [Related]

  • 39. Renal transplantation in cyclosporine-treated recipients at the Singapore General Hospital.
    Vathsala A, Woo KT.
    Clin Transpl; 1999 Jan 27; ():189-97. PubMed ID: 11038637
    [Abstract] [Full Text] [Related]

  • 40. Duration of end-stage renal disease and kidney transplant outcome.
    Goldfarb-Rumyantzev A, Hurdle JF, Scandling J, Wang Z, Baird B, Barenbaum L, Cheung AK.
    Nephrol Dial Transplant; 2005 Jan 27; 20(1):167-75. PubMed ID: 15546892
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.